EUVIMEDEUVIMED entdecken
Crossref

Current status of neonatal jaundice management in Japan

Kazuya Honbe, Masahiro Hayakawa iD, Ichiro Morioka iD, Hiroshi Arai, Yoshihiro Maruo, Takashi Kusaka, Tetsuya Kunikata, Sota Iwatani iD, Akihisa Okumura iD

Pediatrics International · 2023

DOI: 10.1111/ped.15617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, 2023. Verfasst von Kazuya Honbe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Tosei General Hospital, Seto, Japan. Hauptthemen laut MEDLINE: Jaundice, Neonatal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Ministry of Health, Labour, and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This nationwide survey aimed to determine the status of jaundice management in Japan.

Methods

A questionnaire about bilirubin level measurements and neonatal jaundice treatment was sent to 330 institutions providing neonatal care. The responses were analyzed according to institution level.

Results

Of 330 institutions, 172 responded (52.1% response rate). Total bilirubin levels were measured in the central laboratory using spectrophotometry at 134 institutions and a blood gas analyzer at 81 institutions. Unbound bilirubin (UB) levels were measured by 79 institutions, while transcutaneous bilirubin measurements were taken at 63 institutions. There was no association between institution level and UB or transcutaneous bilirubin measurement. For phototherapy criteria, the Murata‐Imura criteria were adopted by 67 institutions, Nakamura criteria by 36, and Morioka criteria by 39. Light‐emitting diodes (LED) were used by 160 institutions versus fluorescent lights by 31. When a blue LED was used, 119 institutions used the high mode. There is no standard for increasing light intensity. No association was found between institution level and phototherapy criteria. UB was measured in 14 of 63 institutions using the Murata‐Imura criteria.

Conclusions

There is a large variation in the management and treatment of neonatal jaundice among institutes in Japan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Jaundice, NeonatalInfant, NewbornHumansJapanExchange Transfusion, Whole BloodPhototherapyBilirubin

Stichwörter der Autor:innen

exchange transfusionneonatal jaundicephototherapypreterm bilirubin encephalopathyunbound bilirubin

Substanzen

Bilirubin

Autor:innen und Institutionen

  • Department of Pediatrics, Tosei General Hospital, Seto, Japan.
  • Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan.
  • Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
  • Department of Pediatric Neurology, Bobath Memorial Hospital, Osaka, Japan.
  • Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
  • Department of Pediatrics, Kagawa University School of Medicine, Miki-cho, Kita-gun, Japan.

ORCID-Profile: Masahiro Hayakawa, Ichiro Morioka, Sota Iwatani, Akihisa Okumura

Förderung

  • Ministry of Health, Labour, and Welfare

Zitieren

APA

Honbe, K., Hayakawa, M., Morioka, I., Arai, H., Maruo, Y., Kusaka, T., Kunikata, T., Iwatani, S., & Okumura, A. (2023). Current status of neonatal jaundice management in Japan. Pediatrics International. https://doi.org/10.1111/ped.15617

Vancouver

Honbe K, Hayakawa M, Morioka I, Arai H, Maruo Y, Kusaka T, et al. Current status of neonatal jaundice management in Japan. Pediatrics International. 2023. doi:10.1111/ped.15617

BibTeX
@article{Honbe2023,
  author = {Honbe, Kazuya and Hayakawa, Masahiro and Morioka, Ichiro and Arai, Hiroshi and Maruo, Yoshihiro and Kusaka, Takashi and Kunikata, Tetsuya and Iwatani, Sota and Okumura, Akihisa},
  title = {Current status of neonatal jaundice management in Japan},
  journal = {Pediatrics International},
  year = {2023},
  doi = {10.1111/ped.15617}
}
Kostenlos starten →